Showing 1 - 10 of 409
In recent years the Russian innovation policy has made a significant progress that manifests in developing its ‘tool … kit', increasing resource base, etc. However it has not yet succeeded in improving business innovation activities that … Russian industrial enterprises the authors analyze key features of innovation in Russian companies under economic recovery, as …
Persistent link: https://www.econbiz.de/10013083716
for international firms engaged both in environmental and in dirty activities. Firms' innovation, measured, as the … the lack of integrated innovation adoption behind environmental productivity performance. In this work, we analyse the …
Persistent link: https://www.econbiz.de/10012961274
position of the US as a locus of innovation in pharmaceuticals has increased over the past decade compared to Europe. All in … European countries. As a whole, Europe is lagging behind in its ability to generate, organise, and sustain innovation processes … in pharmaceuticals: 1) The size and the structure of the biomedical education and research systems; 2) Some basic …
Persistent link: https://www.econbiz.de/10005034968
The article discusses recent advances and future challenges in innovation studies. First, it separately considers four … main strands of research, studying innovation at the organisational, systemic, sectoral and macroeconomic levels. Then … technological and institutional change; the role of demand; and the impacts of innovation on individual and collective welfare …
Persistent link: https://www.econbiz.de/10008764696
We study size and growth distributions of products and business firms in the context of a given industry. Firm size growth is analyzed in terms of two basic mechanisms, i.e. the increase of the number of new elementary business units and their size growth. We find a power-law relationship...
Persistent link: https://www.econbiz.de/10005020505
In 1970 the USA spent 7% of its GNP on healthcare, in 200716%. Whereas the OECD average per capita expenditure on healthcare in 2007 was $2,964, the USA spent $7,290. Yet in that same period, the health of America’s citizens relative to those of other developed countries declined dramatically,...
Persistent link: https://www.econbiz.de/10008544705
The study tests the FDI spillover hypothesis in the Indian Pharmaceutical industry using an unbalanced panel data for a sample of firms over the period 1989-90 to 2000-01. The study estimates firm-specific productive efficiency growth for domestic firms from frontier production function and...
Persistent link: https://www.econbiz.de/10005059093
measures that are affecting demand for pharmaceuticals in all major markets. This Perspective considers the impact of the …
Persistent link: https://www.econbiz.de/10005109573
, which covers both elementary units (products) and classes (markets, firms) in a given industry (pharmaceuticals), covering …
Persistent link: https://www.econbiz.de/10005031401
We study the betweenness centrality of fractal and non-fractal scale-free network models as well as real networks. We show that the correlation between degree and betweenness centrality C of nodes is much weaker in fractal network models compared to non-fractal models. We also show that nodes of...
Persistent link: https://www.econbiz.de/10005031411